Relevant bibliographies by topics / Hopital Henri Mondor (Créteil, France)

Contents

  1. Journal articles
  2. Dissertations / Theses

Academic literature on the topic 'Hopital Henri Mondor (Créteil, France)'

Author: Grafiati
Published: 27 July 2024
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hopital Henri Mondor (Créteil, France).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hopital Henri Mondor (Créteil, France)"

1

Matimbo, Jean Jacques Koyondele, Aliocha Natuhoyila Nkodila, Christophe Duvoux, Francky Mubenga, and Antoine Wola Yaba Tshimpi. "Evaluation of survival of sickle cell patients after liver transplantation at the Henri Mondor Hospital in Créteil (HHM) in France: A Retrospective cohort study." Gastroenterology & Hepatology: Open access 13, no. 3 (2022): 115–19. http://dx.doi.org/10.15406/ghoa.2022.13.00509.

Full text
Abstract:
Background: Hepatic cholestasis is very common in sickle cell disease, thus requiring liver transplantation; but this technique is not practiced in the developing world. The objective of this study was to evaluate the survival of sickle cell patients after liver transplantation followed at the Henri Mondor Hospital in Créteil (HHM) in France. Methods: Historical cohort study conducted in 24 sickle cell patients followed at the Henri Mondor hospital in Créteil in France during the period from 1991 to 2019. The clinical, biological and evolutionary parameters were studied. Patient survival was d
APA, Harvard, Vancouver, ISO, and other styles
2

Pawlotsky, Jean-Michel. "What next for hepatitis B therapy? An interview with Jean-Michel Pawlotsky." Future Virology 14, no. 8 (2019): 507–8. http://dx.doi.org/10.2217/fvl-2019-0064.

Full text
Abstract:
Biography In this exclusive interview, Jean-Michel Pawlotsky discusses present-day and developing therapies for treating hepatitis B viral infection, with a view for future directions and predictions for this currently incurable disease. This interview was conducted by Ellen Colvin, Editor of Future Virology. Dr Jean-Michel Pawlotsky is a Professor of Medicine at the University of Paris-Est, France. He is the Director of the National Reference Center for Viral hepatitis B, C and D and of the Department of Virology at the Henri Mondor University Hospital in Créteil, France, and the Director of
APA, Harvard, Vancouver, ISO, and other styles
3

Gellen, Barnabas, Silvia Oghina, Mijiti Wuliya, et al. "Feasibility of Cardiac Exercise Rehabilitation in Patients with Cardiac Amyloidosis." European Rehabilitation Journal 1, no. 3 (2023): 1–8. http://dx.doi.org/10.52057/erj.v3i1.27.

Full text
Abstract:
Objective: We aimed to determine if prescribed exercise programs in rehabilitation of patients with cardiac amyloidosis was feasible and beneficial. Methods: This prospective monocentric pilot study was proposed to all adult patients, diagnosed with cardiac amyloidosis, and referred to the cardiac rehabilitation centre at the Henri Mondor University hospital (Créteil, France) between 2011 to 2015. All patients had clinical evaluations, laboratory tests, and echocardiographic examinations upon recruitment to the study. The cardiac exercise rehabilitation programme, in this study, comprised a ba
APA, Harvard, Vancouver, ISO, and other styles
4

Bernal, Juan, and Jacques Nunez. "Thyroid hormones and brain development." European Journal of Endocrinology 133, no. 4 (1995): 390–98. http://dx.doi.org/10.1530/eje.0.1330390.

Full text
Abstract:
Bernal J, Nunez J. Thyroid hormones and brain development. Eur J Endocrinol 1995;133:390–8. ISSN 0804–4643 Thyroid hormone is a major physiological regulator of mammalian brain development. Cell differentiation, migration and gene expression are altered as a consequence of thyroid hormone deficiency or excess. The physiological role of thyroid hormone can perhaps be defined so as to ensure the timed coordination of different developmental events through specific effects on the rate of cell differentiation and gene expression. All triiodothyronine (T3) receptor isoforms are expressed in the bra
APA, Harvard, Vancouver, ISO, and other styles
5

Couette, Maryline, Stéphanie Forté, Damien Oudin Doglioni, et al. "Early Strokes Are Associated with More Global Cognitive Deficits in Adults with Sickle Cell Disease." Journal of Clinical Medicine 12, no. 4 (2023): 1615. http://dx.doi.org/10.3390/jcm12041615.

Full text
Abstract:
This study sought to link neurocognitive profiles in sickle cell disease (SCD) patients with clinical characteristics. We conducted a prospective cohort study of adults with SCD who underwent comprehensive neuropsychological assessment at the UMGGR clinic at Henri Mondor Hospital, Créteil (France). A cluster analysis was performed based on neuropsychological testing scores. The association between clusters and clinical profiles was assessed. Between 2017 and 2021, 79 patients with a mean age of 36 [range 19–65] years were included. On principal component analysis, a 5-factor model presented th
APA, Harvard, Vancouver, ISO, and other styles
6

Desforges, Sara-Maude, Kevin H. M. Kuo, Maryline Couette, et al. "Validitation of the Rowland Universal Dementia Assessment Scale (RUDAS) for the Detection of Cognitive Impairment Among Adults with Sickle Cell Disease." Blood 144, Supplement 1 (2024): 5068. https://doi.org/10.1182/blood-2024-209963.

Full text
Abstract:
Background Adults with sickle cell disease (SCD) are at higher risk of cognitive disorder compared to the general population. The American Society of Hematology recommends cognitive screening; however, optimal surveillance strategies have not been established. The Rowland Universal Dementia Assessment Scale (RUDAS) is a short questionnaire that was specifically developed in culturally diverse populations. Objective To determine whether the RUDAS is a valid screening tool to detect cognitive disorder among adults with SCD. Methods This cross-sectional study was conducted between 2018 and 2023 i
APA, Harvard, Vancouver, ISO, and other styles
7

D'Humieres, Thomas, Mathilde Stevenard, Haytham Derbel, et al. "Protection Against Coronary Atherosclerosis in High Cardiovascular Risk Sickle Cell Disease Patients: A Beneficial Role of Intravascular Hemolysis?" Blood 144, Supplement 1 (2024): 3890. https://doi.org/10.1182/blood-2024-209108.

Full text
Abstract:
Background: Sickle Cell Disease (SCD) is linked to various cardiac and systemic vascular disorders, which significantly contribute to both morbidity and mortality. Despite numerous cardiovascular (CV) risk factors, chronic inflammation and endothelial dysfunction, pre-clinical studies suggest a paradoxical protection against atherosclerosis in this population. Purpose: This study aimed to assess the prevalence of coronary artery disease in homozygous sickle cell disease (SCD) patients - also known as sickle cell anemia (SCA) - at high CV risk, to further identify potential determinants or prot
APA, Harvard, Vancouver, ISO, and other styles
8

Kane, Christopher. "Commentary on “Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy.” Campeggi A, Xylinas E, Ploussard G, Ouzaid I, Fabre A, Allory Y, Vordos D, Abbou CC, Salomon L, de la Taille A, Institut National de la Sante et de la Recherche Medicale Unit 955 EQ7, Department of Urology, APHP, CHU Henri Mondor, Créteil, France." Urologic Oncology: Seminars and Original Investigations 31, no. 2 (2013): 274–75. http://dx.doi.org/10.1016/j.urolonc.2013.02.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Forté, Stéphanie, Maryline Couette, Damien Oudin Doglioni, Denis Soulieres, Kevin H. M. Kuo, and Pablo Bartolucci. "Evidence of Educational Bias in Cognitive Screening of Adults with Sickle Cell Disease: Comparison of Available Tools and Possible Strategies for Mitigation." Blood 136, Supplement 1 (2020): 13–14. http://dx.doi.org/10.1182/blood-2020-143169.

Full text
Abstract:
Background: Cognitive impairment is a dreaded complication of sickle cell disease (SCD) that impacts quality of life, school performance and employment. In 2020, the American Society of Hematology issued a strong recommendation that clinicians supervising the care of adults with SCD conduct surveillance for cognitive impairment using simplified signaling questions (DeBaun, 2020). However, guidance on the optimal screening strategy is lacking and several available tools are biased by language and education. The Rowland Universal Dementia Assessment Scale (RUDAS) was specifically designed for co
APA, Harvard, Vancouver, ISO, and other styles
10

Peters, Marion G., H. W. Hann, Paul Martin, et al. "Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ)." Gastroenterology 126, no. 1 (2004): 91–101. http://dx.doi.org/10.1053/j.gastro.2003.10.051.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Hopital Henri Mondor (Créteil, France)"

1

Livache, Karine. "Préparation centralisée des anticancéreux à l'hôpital Henri Mondor : intérêt économique." Paris 5, 1991. http://www.theses.fr/1991PA05P107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography